chlorpromazine hydrochloride and its Impurities
Chlorpromazine Hydrochloride was developed in 1950 and was the first antipsychotic. It is classified as a low-potency typical antipsychotic and in the past was used in the treatment of both acute and chronic psychoses, including schizophrenia and the manic phase of bipolar disorder, as well as amphetamine-induced psychosis.. Reference standards of Chlorpromazine Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below


2-(2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethoxy)ethan-1-ol Dihydrochloride
2-(2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethoxy)ethan-1-ol Dihydrochloride
Catalogue No.:PA 03 0471004
CAS :
1827-91-4
Molecular Formula : C24H32Cl2F3N3O2S
Molecular Weight : 554.49


tert-Butyl 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazine-1-carboxylate
tert-butyl 4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazine-1-carboxylate
Catalogue No.:PA 03 0471005
CAS :
1009797-48-1
Molecular Formula : C25H30F3N3O2S
Molecular Weight : 493.59